{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:11:54Z","timestamp":1790374314987,"version":"4.1.0"},"reference-count":53,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2019.10953","type":"journal-article","created":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T09:41:48Z","timestamp":1570009308000},"source":"Crossref","is-referenced-by-count":26,"title":["A subset of patients with MSS\/MSI\u2011low\u2011colorectal cancer showed increased CD8(+) TILs together with up\u2011regulated IFN\u2011\u03b3"],"prefix":"10.3892","author":[{"given":"Tomohiro","family":"Kikuchi","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960\u20111295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosaku","family":"Mimura","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960\u20111295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Okayama","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960\u20111295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960\u20111295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuharu","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960\u20111295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960\u20111295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisei","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960\u20111295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960\u20111295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960\u20111295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisahito","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960\u20111295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonobu","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960\u20111295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Momma","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960\u20111295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenichiro","family":"Saze","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960\u20111295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Ohki","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960\u20111295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960\u20111295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,10,2]]},"reference":[{"key":"key20200714092211_b1-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"key20200714092211_b2-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20200714092211_b3-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","article-title":"Colorectal cancer","volume":"383","author":"Brenner","year":"2014","journal-title":"Lancet"},{"key":"key20200714092211_b4-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"key20200714092211_b5-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.trecan.2016.02.004","article-title":"The immune biology of microsatellite-unstable cancer","volume":"2","author":"Kloor","year":"2016","journal-title":"Trends Cancer"},{"key":"key20200714092211_b6-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/sj.bjc.6604867","article-title":"Deficient mismatch repair system in patients with sporadic advanced colorectal cancer","volume":"100","author":"Koopman","year":"2009","journal-title":"Br J Cancer"},{"key":"key20200714092211_b7-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","article-title":"Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer","volume":"28","author":"Sargent","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20200714092211_b8-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N Engl J Med"},{"key":"key20200714092211_b9-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","article-title":"Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"Kang","year":"2017","journal-title":"Lancet"},{"key":"key20200714092211_b10-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.eururo.2017.03.037","article-title":"Treatment beyond progression in patients with advanced renal cell carcinoma treated with nivolumab in CheckMate 025","volume":"72","author":"Escudier","year":"2017","journal-title":"Eur Urol"},{"key":"key20200714092211_b11-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med"},{"key":"key20200714092211_b12-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"key20200714092211_b13-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"key20200714092211_b14-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): An open-label, multicentre, phase 2 study","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol"},{"key":"key20200714092211_b15-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"key20200714092211_b16-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00262-012-1303-8","article-title":"T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer","volume":"62","author":"Bauer","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"key20200714092211_b17-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/1078-0432.CCR-15-1678","article-title":"Microsatellite instability as a biomarker for PD-1 blockade","volume":"22","author":"Dudley","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key20200714092211_b18-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"key20200714092211_b19-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ccell.2018.03.010","article-title":"Comparative molecular analysis of gastrointestinal adenocarcinomas","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"key":"key20200714092211_b20-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"12624","DOI":"10.1038\/ncomms12624","article-title":"Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma","volume":"7","author":"Wallin","year":"2016","journal-title":"Nat Commun"},{"key":"key20200714092211_b21-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J Clin Invest"},{"key":"key20200714092211_b22-ol-0-0-10953","first-page":"2030","article-title":"Phospho-STAT1 expression as a potential biomarker for anti-PD-1\/anti-PD-L1 immunotherapy for breast cancer","volume":"54","author":"Nakayama","year":"2019","journal-title":"Int J Oncol"},{"key":"key20200714092211_b23-ol-0-0-10953","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1158\/1541-7786.MCR-18-0831","article-title":"miRNA-148a-3p regulates immunosuppression in DNA mismatch repair-deficient colorectal cancer by targeting PD-L1","volume":"17","author":"Ashizawa","year":"2019","journal-title":"Mol Cancer Res"},{"key":"key20200714092211_b24-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","article-title":"Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): A randomised controlled trial","volume":"387","author":"Herbst","year":"2016","journal-title":"Lancet"},{"key":"key20200714092211_b25-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1158\/1078-0432.CCR-17-3533","article-title":"Glycosyltransferase gene expression identifies a poor prognostic colorectal cancer subtype associated with mismatch repair deficiency and incomplete glycan synthesis","volume":"24","author":"Noda","year":"2018","journal-title":"Clin Cancer Res"},{"key":"key20200714092211_b26-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1158\/1078-0432.CCR-11-3225","article-title":"Molecular pathways: Interferon\/stat1 pathway: Role in the tumor resistance to genotoxic stress and aggressive growth","volume":"18","author":"Khodarev","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20200714092211_b27-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"key20200714092211_b28-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J Clin Oncol"},{"key":"key20200714092211_b29-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1001\/jamaoncol.2015.3638","article-title":"Quantitative assessment of the heterogeneity of PD-L1 expression in non-small-cell lung cancer","volume":"2","author":"McLaughlin","year":"2016","journal-title":"JAMA Oncol"},{"key":"key20200714092211_b30-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/jamaoncol.2015.3782","article-title":"PD-L1 expression as a predictive biomarker: Is absence of proof the same as proof of absence?","volume":"2","author":"Bhaijee","year":"2016","journal-title":"JAMA Oncol"},{"key":"key20200714092211_b31-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1158\/1078-0432.CCR-16-0169","article-title":"Predictive biomarkers for PD-1 axis therapies: The hidden treasure or a call for research","volume":"22","author":"Schalper","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key20200714092211_b32-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrclinonc.2017.88","article-title":"Monitoring immune-checkpoint blockade: Response evaluation and biomarker development","volume":"14","author":"Nishino","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"key20200714092211_b33-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.1016\/S1470-2045(16)30406-5","article-title":"Predictive biomarkers for checkpoint inhibitor-based immunotherapy","volume":"17","author":"Gibney","year":"2016","journal-title":"Lancet Oncol"},{"key":"key20200714092211_b34-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/cas.12503","article-title":"Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-gamma treatment","volume":"105","author":"Mimura","year":"2014","journal-title":"Cancer Sci"},{"key":"key20200714092211_b35-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/cas.13424","article-title":"PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer","volume":"109","author":"Mimura","year":"2018","journal-title":"Cancer Sci"},{"key":"key20200714092211_b36-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/bjc.2015.213","article-title":"Microsatellite instable vs. stable colon carcinomas: Analysis of tumour heterogeneity, inflammation and angiogenesis","volume":"113","author":"De Smedt","year":"2015","journal-title":"Br J Cancer"},{"key":"key20200714092211_b37-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"e29256","DOI":"10.4161\/onci.29256","article-title":"Characterization of an adaptive immune response in microsatellite-instable colorectal cancer","volume":"3","author":"Boissi\u00e8re-Michot","year":"2014","journal-title":"Oncoimmunology"},{"key":"key20200714092211_b38-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: A prognostic and accuracy study","volume":"391","author":"Pag\u00e8s","year":"2018","journal-title":"Lancet"},{"key":"key20200714092211_b39-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1136\/gut.2007.123794","article-title":"High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas","volume":"57","author":"Le Gouvello","year":"2008","journal-title":"Gut"},{"key":"key20200714092211_b40-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/sj.bjc.6604756","article-title":"High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability","volume":"99","author":"Michel","year":"2008","journal-title":"Br J Cancer"},{"key":"key20200714092211_b41-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","article-title":"Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer","volume":"27","author":"Salama","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20200714092211_b42-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.1073\/pnas.0913683107","article-title":"In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction","volume":"107","author":"Blatner","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200714092211_b43-ol-0-0-10953","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/ijc.24989","article-title":"High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients","volume":"126","author":"Frey","year":"2010","journal-title":"Int J Cancer"},{"key":"key20200714092211_b44-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1371\/journal.pone.0000129","article-title":"CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer","volume":"1","author":"Clarke","year":"2006","journal-title":"PLoS One"},{"key":"key20200714092211_b45-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1479-5876-4-52","article-title":"In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer","volume":"4","author":"Loddenkemper","year":"2006","journal-title":"J Transl Med"},{"key":"key20200714092211_b46-ol-0-0-10953","first-page":"7","article-title":"Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients","volume":"7","author":"Ling","year":"2007","journal-title":"Cancer Immun"},{"key":"key20200714092211_b47-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1136\/gutjnl-2016-311421","article-title":"Tumour CD274 (PD-L1) expression and T cells in colorectal cancer","volume":"66","author":"Masugi","year":"2017","journal-title":"Gut"},{"key":"key20200714092211_b48-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nri3605","article-title":"Homeostatic control of regulatory T cell diversity","volume":"14","author":"Liston","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"key20200714092211_b49-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"610","DOI":"10.21037\/jgo.2018.05.06","article-title":"Beyond microsatellite testing: Assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition","volume":"9","author":"Fabrizio","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"key20200714092211_b50-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1001\/jamaoncol.2018.7098","article-title":"Assessment of blood tumor mutational burden as a potential biomarker for immunotherapy in patients with non-small cell lung cancer with use of a next-generation sequencing cancer gene panel","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol"},{"key":"key20200714092211_b51-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: Utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann Oncol"},{"key":"key20200714092211_b52-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/jamaoncol.2019.0536","article-title":"Association of primary resistance to immune checkpoint inhibitors in metastatic colorectal cancer with misdiagnosis of microsatellite instability or mismatch repair deficiency status","volume":"5","author":"Cohen","year":"2019","journal-title":"JAMA Oncol"},{"key":"key20200714092211_b53-ol-0-0-10953","doi-asserted-by":"publisher","first-page":"404","DOI":"10.21037\/jgo.2018.01.09","article-title":"Immune profiling of microsatellite instability-high and polymerase epsilon (POLE)-mutated metastatic colorectal tumors identifies predictors of response to anti-PD-1 therapy","volume":"9","author":"Wang","year":"2018","journal-title":"J Gastrointest Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T11:25:21Z","timestamp":1721820321000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2019.10953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,2]]},"references-count":53,"URL":"https:\/\/doi.org\/10.3892\/ol.2019.10953","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,2]]}}}